Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone

For more than 20 years, Copaxone (glatiramer acetate, Teva), a non-biological complex drug, has been a safe and effective treatment option for multiple sclerosis. In 2016, a follow-on glatiramer acetate product (FOGA, Synthon) was approved in the EU. Traditional bulk-based methods and high-resolutio...

Full description

Bibliographic Details
Main Authors: S. Melamed-Gal, P. Loupe, B. Timan, V. Weinstein, S. Kolitz, J. Zhang, J. Funt, A. Komlosh, N. Ashkenazi, O. Bar-Ilan, A. Konya, O. Beriozkin, D. Laifenfeld, T. Hasson, R. Krispin, T. Molotsky, G. Papir, L. Sulimani, B. Zeskind, P. Liu, S. Nock, M.R. Hayden, A. Gilbert, I. Grossman
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:eNeurologicalSci
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650218300194